Despite the revenue growth, Lumexa reported a net loss of $28.7 million for the fourth quarter, compared to a loss of $25.1 million in the prior year. Adjusted EBITDA for the quarter was $63.8 million, reflecting an 18.6% increase from $53.7 million, with a margin of 23.8%. The company also highlighted a significant reduction in leverage, decreasing from 5.5 times to 3.5 times, resulting in over $50 million in annual cash savings.
Looking ahead, Lumexa reiterated its guidance for the full year 2026, expecting consolidated revenues between $1.045 billion and $1.097 billion, with Adjusted EBITDA projected between $234 million and $242 million. The company anticipates continued growth driven by strong demand for outpatient imaging services and the opening of new centers. CEO Caitlin Zulla expressed optimism about the company's strategic focus on same-center growth and geographic expansion, positioning Lumexa for sustained, profitable growth in the coming years.
The preliminary results are unaudited and subject to final review, and the company cautioned that actual results may differ materially from these estimates. The information provided in the filing is not to be considered 'filed' under the Securities Exchange Act unless explicitly stated. Lumexa will host a conference call to discuss these results and its outlook on March 26, 2026, at 8:30 a.m. ET.
